High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2019

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Metastatic Pancreatic CancerPancreatic CancerPancreas CancerPancreatic Adenocarcinoma ResectablePancreatic Ductal AdenocarcinomaPancreatic Metastasis
Interventions
DRUG

Ascorbic Acid

25, 37.5, 56.25 or 75 grams/m2

DRUG

Paclitaxel protein-bound

125mg/m2 over 30 minute IV infusions on days 1 and 8 repeated every 21 days

DRUG

Cisplatin

25mg/m2 in 500\*mL of NS over 60minute IV infusion on days 1 and 8 repeated every 21 days

DRUG

Gemcitabine

1000mg/m2 in 500\*mL over 30 minute IV infusion on days 1 and 8 repeated every 21 days

Trial Locations (1)

92093

UC San Diego Moores Cancer Center, La Jolla

All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

Stand Up To Cancer

OTHER

collaborator

Lustgarten Foundation

OTHER

collaborator

Destroy Pancreatic Cancer

OTHER

collaborator

Translational Genomics Research Institute

OTHER

collaborator

HonorHealth Research Institute

OTHER

lead

Hitendra Patel

OTHER